GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Decision Diagnostics Corp (OTCPK:DECN) » Definitions » Forward Dividend Yield %

Decision Diagnostics (Decision Diagnostics) Forward Dividend Yield % : 0.00% (As of Apr. 29, 2024)


View and export this data going back to . Start your Free Trial

What is Decision Diagnostics Forward Dividend Yield %?

As of today (2024-04-29), the Forward Annual Dividend Yield of Decision Diagnostics is 0.00%.

As of today (2024-04-29), the Trailing Annual Dividend Yield of Decision Diagnostics is 0.00%.

DECN's Forward Dividend Yield % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.28
* Ranked among companies with meaningful Forward Dividend Yield % only.

Decision Diagnostics's Dividends per Share for the three months ended in Sep. 2021 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Decision Diagnostics's Forward Dividend Yield %

For the Pharmaceutical Retailers subindustry, Decision Diagnostics's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Decision Diagnostics's Forward Dividend Yield % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Decision Diagnostics's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Decision Diagnostics's Forward Dividend Yield % falls into.



Decision Diagnostics Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Decision Diagnostics  (OTCPK:DECN) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Decision Diagnostics Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Decision Diagnostics's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Decision Diagnostics (Decision Diagnostics) Business Description

Traded in Other Exchanges
N/A
Address
2660 Townsgate Road, Suite 300, Westlake Village, CA, USA, 91361
Decision Diagnostics Corp is a provider of prescription drugs, home testing products for the chronically ill, direct to patient diabetes programs, and a developer of revolutionary, cell phone centric, e-health products and technology. The company also provides blood glucose home testing test strips and exciting new concepts for blood testing monitors.
Executives
Keith Berman director, officer: Secretary 2660 TOWNSGATE RD #300, WESTLAKE VILLAGE CA 91361
Robert Jagunich director 765 CHRISTINE DR PALO ALTO CA 94303
Robert Lawrence Cox director, officer: President

Decision Diagnostics (Decision Diagnostics) Headlines

From GuruFocus

DECN Comments on Recent Legal Filings by Federal Agencies

By ACCESSWIRE ACCESSWIRE 12-19-2020